Predictive Biomarkers for Gemcitabine as a Chemoradiosensitizer in Bladder Cancer

類似資料

• Gemcitabine as a Chemoradiosensitiser in Bladder Cancer
  著者:: Kerr, M, 等
  出版事項: (2012)
• Gemcitabine-Resistant Biomarkers in Bladder Cancer are Associated with Tumor-Immune Microenvironment
  著者:: Yuxuan Song, 等
  出版事項: (2022-01-01)
• Magnetite nanoparticles as a kinetically favorable source of iron to enhance GBM response to chemoradiosensitization with pharmacological ascorbate
  著者:: M.S. Petronek, 等
  出版事項: (2023-06-01)
• Does Reorganization of Clinicopathological Information Improve Prognostic Stratification and Prediction of Chemoradiosensitivity in Sinonasal Carcinomas? A Retrospective Study on 145 Patients
  著者:: Marco Ferrari, 等
  出版事項: (2022-06-01)
• A multicentre NCRI phase II study of hypofractionated conformal radiotherapy with concurrent gemcitabine in muscle-invasive bladder cancer
  著者:: Choudhury, A, 等
  出版事項: (2010)